Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement in cystic fibrosis.

R G Strauss

    Helvetica Paediatrica Acta
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    This study assessed complement pathways in cystic fibrosis patients, finding no complement deficiency. While Factor B activated more readily in patients, it did not lead to increased complement component consumption.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions.

    Vox sanguinis·2017
    Same author

    Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.

    Vox sanguinis·2016
    Same author

    Education in transfusion medicine for medical students and doctors.

    Vox sanguinis·2013
    Same author

    Preparation of granulocyte concentrates by apheresis: collection modalities in the USA.

    Vox sanguinis·2011
    Same author

    Neonatal transfusions.

    Vox sanguinis·2009
    Same author

    The future use of pathogen-inactivated platelet concentrates.

    Vox sanguinis·2003

    Area of Science:

    • Immunology
    • Complement System Biology

    Background:

    • Cystic fibrosis (CF) is a genetic disorder affecting multiple organs.
    • The complement system plays a crucial role in innate immunity.
    • Dysregulation of the complement system may contribute to CF pathogenesis.

    Purpose of the Study:

    • To quantitatively and functionally assess the classical and alternative complement pathways in cystic fibrosis patients.
    • To determine if complement deficiencies exist in cystic fibrosis.
    • To investigate the activation patterns of complement components, specifically Factor B.

    Main Methods:

    • Sera from 23 cystic fibrosis patients and controls were analyzed.
    • Classical pathway function was measured by CH50 titre.
    • Alternative pathway function was assessed by inulin-initiated Factor B cleavage, C3 cleavage, and terminal component consumption.

    Related Experiment Videos

    Main Results:

    • Classical complement pathway function was similar in cystic fibrosis patients and controls.
    • Alternative pathway function, measured by Factor B cleavage and C3 consumption, was comparable between patients and controls.
    • Factor B showed increased activation in cystic fibrosis patient sera, but this did not result in accelerated or more extensive terminal complement component activation.

    Conclusions:

    • No overall complement deficiency was identified in the studied cystic fibrosis patients.
    • The significance of the readily activated Factor B in cystic fibrosis remains undetermined.
    • Complement system function appears largely intact in cystic fibrosis despite altered Factor B activation.